Prof. Sean P. J. Whelan

Vesicular stomatitis virus vectored vaccine for SARS-CoV-2

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA

Prof. Dor Ben-Amotz

Optimally Pooled COVID-19 Testing

Purdue University, Department of Chemistry West Lafayette, IN, USA

Prof. Rafael Franco

The renin angiotensin system (RAS) involvement in SARS-CoV-2 infection. ACE2 interacts with other RAS components to form complexes that are expressed in the lung.

Universidad de Barcelona. Barcelona, Spain

Dr Delia Goletti

Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies

National Institute for Infectious Disease L. Spallanzani, Rome, Italy

Prof. Y-h. Taguchi

In silico drug discovery for COVID-19 using gene expression profiles of mouse infected by MHV and those of human cell lines infected by SARS-CoV-2

Department of Physics, Chuo University, Tokyo, Japan

Prof. Dr Barry Robson

Internet Knowledge Mining tools and A.I. For Rapid Response to New Pandemics with Proposals for Synthetic Vaccines and Therapeutics. The Example of COVID19

Ingine Inc. Cleveland Ohio, USA

Prof. Manuela Teresa Raimondi

Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19

Politecnico di Milano, Milano, Italy

Prof. Antonio Bianconi

Contolling the second Covid-19 wave by Mandatory Mobile Contact Tracing (MMCT) Containment and Time Dependent Doubling Time Control

Rome International Center for Materials Science, Superstripes, Roma, Italy

Prof. Craig B. Wilen

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Yale School of Medicine Departments of Laboratory Medicine & Immunobiology, New Haven, USA

Prof. Rushika Perera

Innovative Therapeutic Interventions for SARS-CoV-2 – exploiting metabolic synergy

Arthropod-borne & Infectious Diseases Laboratory Colorado State University, USA

Prof. Maurizio Salvadori

SARS-CoV-2 Associated Nephropathy in the Pandemic Era

Department of Nephrology and Transplantation, University of Florence, Florence, Italy

Prof. Licia Iacoviello

COVID 19 Risk factors and therapies in Italy: results from the CORIST collaboration

IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy

Dr Tibor Bakács

Dr Tibor Bakács

The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections

Hungarian Academy of Sciences & HepC Inc, Hungary

Dr Jeremy W Prokop

SARS-CoV-2 mechanisms of severe outcomes

Department of Pharmacology & Toxicology, Michigan State University, Grand Rapids, USA

Prof. Susan R. Weiss

Coronaviruses: History and Biology

Penn Center for Research on Coronaviruses & Emerging Pathogens, University of Pennsylvania, USA

Prof. Jianyu Rao

Potential connections of COVID-19 and prostate cancer – the TMPRSS2 story

UCLA Medical Center, Santa Monica, LA, USA

Dr Bruna Corradetti

Stem cells from gestational tissues: a promising tool to restore the body’s own potential to fight SARS-CoV-2 infections

Houston Methodist Research Institute, USA

Prof. Panagiotis Skendros

Complement and neutrophil-mediated immunothrombosis: lessons from COVID-19

Democritus University of Thrace (DUTH), University Hospital of Alexandroupolis, Greece

Prof. Adela Cota-Gomez

Targeting the Master Regulator of Cellular Redox Homeostasis, Nrf2, in SARS-CoV-2 Infection

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, USA

Dr Busra Aktas

Gut-lung axis in COVID-19

Burdur Mehmet Akif Ersoy University, Burdur, Turkey

Prof. Ravi Mahalingam

Lessons learned from animal models of COVID-19

University of Colorado Anschutz Medical Campus, USA

Prof. Mircea T. Sofonea

Epidemiological monitoring and comparative analysis of non-pharmaceutical interventions using a non-Markovian modelling framework

University of Montpellier, France

Prof. Eleftherios Mylonakis

Spatiotemporal analysis of micro-epidemics of influenza and COVID-19

Alpert Medical School of Brown University, Rhode Island Hospital & The Miriam Hospital, USA

Prof. James Cai

Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2

Texas A&M University, USA

Dr Laura Lamb

Developing a Point-of-Risk Molecular Test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan, USA

Dr Corrado Pelaia

Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications

University “Magna Græcia” of Catanzaro, Italy

Dr Hanalise V Huff

Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies

Boston Children’s Hospital, Harvard Medical School, USA

Prof. Mikhail Sheianov

Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe COVID-19. Unusual Treatment with Intriguing Results

Burnasyan Federal Medical Biophysical Center,Moscow, Russia

Prof. Antonio Facchiano

Molecular basis of COVID-19 comorbidities

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

Prof. Luis Beltrán Ramos-Sánchez


University of Camagüey, Camagüey, Cuba

Prof. Padma Srikanth

Covid-19, The King of 2020: lessons learned and still learning from a tertiary care centre in Chennai, India

Dept of Microbiology, Sri Ramachandra Institute, India

Dr Michael Baclig

Laboratory Biosafety in the Time of COVID-19

St. Luke’s Medical Center, Philippines

Christian Arias Reyes

The higher the altitude the less COVID-19: Decreased incidence, transmission capacity of the virus and severity at altitude in the American continent

Faculty of Medicine, Université Laval, Québec, QC, Canada

Dr Johan Lundberg

COVID-19 pathophysiology may be driven by a loss of inhibition of the Renin-Angiotensin-Aldosterone System

Karolinska University Hospital, Stockholm, Sweden

Dr. Manos Vlasiou

Screening Possible Drug Molecules for Covid-19: A Computational Study based on Docking Studies & Molecular Dynamics to Design New Inhibitor Candidates

Department of Health and Life Sciences, University of Nicosia, Nicosia, Cyprus

Prof. A. Ozlem Tastan Bishop

Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations

Department of Biochemistry and Microbiology, Rhodes University, South Africa

Dr Syed Sikander Azam

Vaccine and Drug Designing for COVID-19- Research and Prevention Strategies

Quaid-i-Azam University, Islamabad, Pakistan

Dr. Muhamed Amin

How Molecular Modelling Could help in the COVID19 Crisis

University of Groningen, Groningen, Netherlands

Dr Dicky L. Tahapary

Weighing The Impact of Obesity on COVID-19 in Low- to Middle-Income Countries

Faculty of Medicine Universitas Indonesia (RSCM-FKUI), Indonesia

Dr Mushtaq Hussain

Allelic Variations in ACE2 and Natural Resistance against COVID-19

Dow University of Health Sciences, Karachi, Pakistan

Dr Efstratios Stratikos

Generation of SARS-CoV-2 S1 spike glycoprotein putative antigenic epitopes in vitro by intracellular aminopeptidases

National Center for Scientific Research Demokritos, Greece

★ Agenda is being updated regularly